Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Blood Transfusion = Trasfusione Del Sangue|January 13, 2025
First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trialVeronica Boero, Carlotta Caia, Giulia E Cetera, et al.European Journal of Medicinal Chemistry|May 3, 2025
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylationGiulia Cazzaniga, Davide Capelli, Roberta Montanari, et al.Transfusion|January 18, 2026
Characterization of allogeneic platelet gel from adult donor blood and umbilical cord blood activated with locally prepared cryoprecipitate and thrombin: A pilot exerciseLarysa Mykhailova, Paolo Rebulla, Stefania Villa, et al.Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial InfectionsMatteo Mori, Giovanni Stelitano, Anna Griego, et al.European Journal of Medicinal Chemistry|January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessusMatteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.European Journal of Medicinal Chemistry|March 22, 2017
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory propertiesFederica Porta, Giorgio Facchetti, Nicola Ferri, et al.European Journal of Medicinal Chemistry|June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agentsLaurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.European Journal of Internal Medicine|May 24, 2023
Anemia management and transfusion strategy in internal medicine units: Less is moreDeborah Blanca, Giorgio Parrella, Dario Consonni, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agentsLaurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.Pharmaceutics|February 25, 2023
Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous MycobacteriaMatteo Mori, Giovanni Stelitano, Giulia Cazzaniga, et al.Pageof 7